▎Edited by the WuXi AppTec content team

The company's Enki technology platform is based on generative AI algorithms, aiming to simplify the generation of innovative molecular structures. Similar to generative AI platforms like DALL-E and Midjourney, which create customized, entirely new images based on users' textual requests,Researchers only need to provide the target product profile (TPP) of the compound, including requirements for small molecule compounds such as targets and off-target effects. The Enki technology platform can then generate innovative, selective, and synthetically feasible small molecule structures that meet the TPP requirements.They have the potential to become lead compounds.

"AI is accelerating in drug discovery," said Handol Kim, CEO of Variational AI. "Using the Enki technology platform, chemists don't need to develop their own generative AI models; they just need to provide TPP to obtain diverse, selective, and synthetically feasible innovative small molecule structures within days, allowing them to quickly move into the lead optimization phase."

Everyone is watching

▲To learn more about the application of cutting-edge technologies in the biopharmaceutical industry, please long-press and scan the QR code above to access "WuXi Live Studio" and watch live discussions and exciting replays on related topics.

Disclaimer: The content team of WuXi AppTec focuses on introducing the research progress in global biopharmaceuticals and health. This article is for information exchange purposes only, and the views expressed in the article do not represent the position of WuXi AppTec, nor does it indicate that WuXi AppTec supports or opposes these views. This article is not a recommendation for treatment plans. For guidance on treatment options, please visit a正规 hospital.

Copyright Statement: This article is from the content team of WuXi AppTec. Individuals are welcome to share it on their social media platforms, but unauthorized reproduction by media or organizations in any form to other platforms is strictly prohibited. For authorization to reproduce, please reply with "reprint" on the "WuXi AppTec" WeChat Official Account to obtain reprint guidelines.